Correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri and the sul genes

The aim of this study was to discuss the correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri (S. flexneri) and the antibiotic resistance genes sul1, sul2, and sul3 and SXT element.From May 2013 to October 2018, 102 isolates of S. flexneri were collected from the cli...

Full description

Saved in:
Bibliographic Details
Published inMedicine (Baltimore) Vol. 100; no. 10; p. e24970
Main Authors Ma, Quanping, Zhu, Chengbao, Yao, Mingxiao, Yuan, Guangying, Sun, Yuguo
Format Journal Article
LanguageEnglish
Published United States Lippincott Williams & Wilkins 12.03.2021
Subjects
Online AccessGet full text
ISSN0025-7974
1536-5964
1536-5964
DOI10.1097/MD.0000000000024970

Cover

Loading…
Abstract The aim of this study was to discuss the correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri (S. flexneri) and the antibiotic resistance genes sul1, sul2, and sul3 and SXT element.From May 2013 to October 2018, 102 isolates of S. flexneri were collected from the clinical samples in Jinan. The Kirby-Bauer (K-B) test was employed to determine the antibiotic susceptibility of the S. flexneri isolates. The antibiotic resistance rate was analyzed with the WHONET5.4 software. The isolates were subject to the PCR amplification of the sul genes (sul1, sul2, and sul3) and the SXT element. On the basis of the sequencing results, the correlation between the sulfamethoxazole-trimethoprim resistance of the S. flexneri isolates and the sul genes was analyzed.The antibiotic resistance rates of the 102 S. flexneri isolates to ampicillin, streptomycin, chloramphenicol, tetracycline, and sulfamethoxazole-trimethoprim were 90.2%, 90.2%, 88.2%, 88.2%, and 62.7%, respectively. The antibiotic resistance rates of these isolates to cefotaxime, ceftazidime, and ciprofloxacin varied between 20% and 35%. However, these isolates were 100% susceptible to cefoxitin. Positive fragments were amplified from 59.8% (61/102) of the 102 S. flexneri isolates, the sizes of the sul1 and sul2 genes being 338 bp and 286 bp, respectively. The sequence alignment revealed the presence of the sul1 and sul2 genes encoding for dihydrofolate synthase. The carrying rate of the sul1 gene was 13.7% (14/102), and that of the sul2 gene was 48.0% (49/102). No target gene fragments were amplified from the 3 isolates resistant to sulfamethoxazole-trimethoprim. The sul3 gene and SXT element were not amplified from any of the isolates. The testing and statistical analysis showed that the resistance of the S. flexneri isolates to sulfamethoxazole-trimethoprim correlated to the sul1 and sul2 genes.The acquired antibiotic resistance genes sul1 and sul2 were closely associated with the resistance of the 102 S. flexneri isolates to sulfamethoxazole-trimethoprim.
AbstractList The aim of this study was to discuss the correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri ( S. flexneri ) and the antibiotic resistance genes sul1 , sul2, and sul3 and SXT element . From May 2013 to October 2018, 102 isolates of S. flexneri were collected from the clinical samples in Jinan. The Kirby–Bauer (K-B) test was employed to determine the antibiotic susceptibility of the S. flexneri isolates. The antibiotic resistance rate was analyzed with the WHONET5.4 software. The isolates were subject to the PCR amplification of the sul genes ( sul1 , sul2 , and sul3 ) and the SXT element . On the basis of the sequencing results, the correlation between the sulfamethoxazole-trimethoprim resistance of the S. flexneri isolates and the sul genes was analyzed. The antibiotic resistance rates of the 102 S. flexneri isolates to ampicillin, streptomycin, chloramphenicol, tetracycline, and sulfamethoxazole-trimethoprim were 90.2%, 90.2%, 88.2%, 88.2%, and 62.7%, respectively. The antibiotic resistance rates of these isolates to cefotaxime, ceftazidime, and ciprofloxacin varied between 20% and 35%. However, these isolates were 100% susceptible to cefoxitin. Positive fragments were amplified from 59.8% (61/102) of the 102 S. flexneri isolates, the sizes of the sul1 and sul2 genes being 338 bp and 286 bp, respectively. The sequence alignment revealed the presence of the sul1 and sul2 genes encoding for dihydrofolate synthase. The carrying rate of the sul1 gene was 13.7% (14/102), and that of the sul2 gene was 48.0% (49/102). No target gene fragments were amplified from the 3 isolates resistant to sulfamethoxazole-trimethoprim. The sul3 gene and SXT element were not amplified from any of the isolates. The testing and statistical analysis showed that the resistance of the S. flexneri isolates to sulfamethoxazole-trimethoprim correlated to the sul1 and sul2 genes. The acquired antibiotic resistance genes sul1 and sul2 were closely associated with the resistance of the 102 S. flexneri isolates to sulfamethoxazole-trimethoprim.
The aim of this study was to discuss the correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri (S. flexneri) and the antibiotic resistance genes sul1, sul2, and sul3 and SXT element.From May 2013 to October 2018, 102 isolates of S. flexneri were collected from the clinical samples in Jinan. The Kirby-Bauer (K-B) test was employed to determine the antibiotic susceptibility of the S. flexneri isolates. The antibiotic resistance rate was analyzed with the WHONET5.4 software. The isolates were subject to the PCR amplification of the sul genes (sul1, sul2, and sul3) and the SXT element. On the basis of the sequencing results, the correlation between the sulfamethoxazole-trimethoprim resistance of the S. flexneri isolates and the sul genes was analyzed.The antibiotic resistance rates of the 102 S. flexneri isolates to ampicillin, streptomycin, chloramphenicol, tetracycline, and sulfamethoxazole-trimethoprim were 90.2%, 90.2%, 88.2%, 88.2%, and 62.7%, respectively. The antibiotic resistance rates of these isolates to cefotaxime, ceftazidime, and ciprofloxacin varied between 20% and 35%. However, these isolates were 100% susceptible to cefoxitin. Positive fragments were amplified from 59.8% (61/102) of the 102 S. flexneri isolates, the sizes of the sul1 and sul2 genes being 338 bp and 286 bp, respectively. The sequence alignment revealed the presence of the sul1 and sul2 genes encoding for dihydrofolate synthase. The carrying rate of the sul1 gene was 13.7% (14/102), and that of the sul2 gene was 48.0% (49/102). No target gene fragments were amplified from the 3 isolates resistant to sulfamethoxazole-trimethoprim. The sul3 gene and SXT element were not amplified from any of the isolates. The testing and statistical analysis showed that the resistance of the S. flexneri isolates to sulfamethoxazole-trimethoprim correlated to the sul1 and sul2 genes.The acquired antibiotic resistance genes sul1 and sul2 were closely associated with the resistance of the 102 S. flexneri isolates to sulfamethoxazole-trimethoprim.ABSTRACTThe aim of this study was to discuss the correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri (S. flexneri) and the antibiotic resistance genes sul1, sul2, and sul3 and SXT element.From May 2013 to October 2018, 102 isolates of S. flexneri were collected from the clinical samples in Jinan. The Kirby-Bauer (K-B) test was employed to determine the antibiotic susceptibility of the S. flexneri isolates. The antibiotic resistance rate was analyzed with the WHONET5.4 software. The isolates were subject to the PCR amplification of the sul genes (sul1, sul2, and sul3) and the SXT element. On the basis of the sequencing results, the correlation between the sulfamethoxazole-trimethoprim resistance of the S. flexneri isolates and the sul genes was analyzed.The antibiotic resistance rates of the 102 S. flexneri isolates to ampicillin, streptomycin, chloramphenicol, tetracycline, and sulfamethoxazole-trimethoprim were 90.2%, 90.2%, 88.2%, 88.2%, and 62.7%, respectively. The antibiotic resistance rates of these isolates to cefotaxime, ceftazidime, and ciprofloxacin varied between 20% and 35%. However, these isolates were 100% susceptible to cefoxitin. Positive fragments were amplified from 59.8% (61/102) of the 102 S. flexneri isolates, the sizes of the sul1 and sul2 genes being 338 bp and 286 bp, respectively. The sequence alignment revealed the presence of the sul1 and sul2 genes encoding for dihydrofolate synthase. The carrying rate of the sul1 gene was 13.7% (14/102), and that of the sul2 gene was 48.0% (49/102). No target gene fragments were amplified from the 3 isolates resistant to sulfamethoxazole-trimethoprim. The sul3 gene and SXT element were not amplified from any of the isolates. The testing and statistical analysis showed that the resistance of the S. flexneri isolates to sulfamethoxazole-trimethoprim correlated to the sul1 and sul2 genes.The acquired antibiotic resistance genes sul1 and sul2 were closely associated with the resistance of the 102 S. flexneri isolates to sulfamethoxazole-trimethoprim.
The aim of this study was to discuss the correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri (S. flexneri) and the antibiotic resistance genes sul1, sul2, and sul3 and SXT element.From May 2013 to October 2018, 102 isolates of S. flexneri were collected from the clinical samples in Jinan. The Kirby-Bauer (K-B) test was employed to determine the antibiotic susceptibility of the S. flexneri isolates. The antibiotic resistance rate was analyzed with the WHONET5.4 software. The isolates were subject to the PCR amplification of the sul genes (sul1, sul2, and sul3) and the SXT element. On the basis of the sequencing results, the correlation between the sulfamethoxazole-trimethoprim resistance of the S. flexneri isolates and the sul genes was analyzed.The antibiotic resistance rates of the 102 S. flexneri isolates to ampicillin, streptomycin, chloramphenicol, tetracycline, and sulfamethoxazole-trimethoprim were 90.2%, 90.2%, 88.2%, 88.2%, and 62.7%, respectively. The antibiotic resistance rates of these isolates to cefotaxime, ceftazidime, and ciprofloxacin varied between 20% and 35%. However, these isolates were 100% susceptible to cefoxitin. Positive fragments were amplified from 59.8% (61/102) of the 102 S. flexneri isolates, the sizes of the sul1 and sul2 genes being 338 bp and 286 bp, respectively. The sequence alignment revealed the presence of the sul1 and sul2 genes encoding for dihydrofolate synthase. The carrying rate of the sul1 gene was 13.7% (14/102), and that of the sul2 gene was 48.0% (49/102). No target gene fragments were amplified from the 3 isolates resistant to sulfamethoxazole-trimethoprim. The sul3 gene and SXT element were not amplified from any of the isolates. The testing and statistical analysis showed that the resistance of the S. flexneri isolates to sulfamethoxazole-trimethoprim correlated to the sul1 and sul2 genes.The acquired antibiotic resistance genes sul1 and sul2 were closely associated with the resistance of the 102 S. flexneri isolates to sulfamethoxazole-trimethoprim.
Author Yao, Mingxiao
Sun, Yuguo
Yuan, Guangying
Ma, Quanping
Zhu, Chengbao
AuthorAffiliation Department of Clinical Laboratory, Jinan Infectious Disease Hospital Affiliated to Shandong University
Department of Clinical Laboratory, The Fourth People's Hospital of Jinan
Department of Viral Infectious Diseases Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan
AuthorAffiliation_xml – name: Department of Clinical Laboratory, Jinan Infectious Disease Hospital Affiliated to Shandong University
– name: Department of Clinical Laboratory, The Fourth People's Hospital of Jinan
– name: Department of Viral Infectious Diseases Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan
– name: d Collaborative Innovation Center for the Origin and Control of Emerging Infectious Diseases, Taishan Medical University, Taian, Shandong Province 271016, China
– name: a Department of Clinical Laboratory, The Fourth People's Hospital of Jinan
– name: c Department of Viral Infectious Diseases Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan
– name: b Department of Clinical Laboratory, Jinan Infectious Disease Hospital Affiliated to Shandong University
Author_xml – sequence: 1
  givenname: Quanping
  surname: Ma
  fullname: Ma, Quanping
  organization: Department of Clinical Laboratory, The Fourth People's Hospital of Jinan
– sequence: 2
  givenname: Chengbao
  surname: Zhu
  fullname: Zhu, Chengbao
  organization: Department of Clinical Laboratory, Jinan Infectious Disease Hospital Affiliated to Shandong University
– sequence: 3
  givenname: Mingxiao
  surname: Yao
  fullname: Yao, Mingxiao
  organization: Department of Viral Infectious Diseases Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan
– sequence: 4
  givenname: Guangying
  surname: Yuan
  fullname: Yuan, Guangying
  organization: Department of Clinical Laboratory, Jinan Infectious Disease Hospital Affiliated to Shandong University
– sequence: 5
  givenname: Yuguo
  surname: Sun
  fullname: Sun, Yuguo
  organization: Department of Clinical Laboratory, The Fourth People's Hospital of Jinan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33725864$$D View this record in MEDLINE/PubMed
BookMark eNp9UctuFDEQtFAQ2QS-AAnNkcsEv2Y8viChDS8pEQfgbDme9o7Bawfbw4Z8fby7WR454Eu521XV7e4TdBRiAISeE3xGsBSvLs_P8J9DuRT4EVqQjvVtJ3t-hBY127VCCn6MTnL-hjFhgvIn6JhV7IaeL9BqGVMCr4uLobmCsgEITZmgybO3eg1lijf6NnpoS3K78LpikyC7XHQw0ETbfJ7cCrzXjfVwEyC5Rofx4NKsIEB-ih5b7TM8u8dT9PXd2y_LD-3Fp_cfl28uWsM7PLSmdowNgbGT0o49ED5Yy_qxN0ywQYih3s2AqeVUgrEU855rNowEKDOGYXaKXu99r-erNYwGQknaq23TOv1SUTv170twk1rFn0rIXlIpq8HLe4MUf8yQi1q7bLa_CxDnrGp_lOK-jrZSX_xd63eRw3QrQe4JJsWcE1hlXNmNupZ2XhGstptUl-fq4Sarlj3QHuz_r-J71Sb6Ail_9_MGkppA-zLt6J2QtKWYEswIxe02M7A7eY2xwg
CitedBy_id crossref_primary_10_3390_antibiotics11111531
crossref_primary_10_3389_fmicb_2023_1192769
crossref_primary_10_1007_s10123_023_00472_9
crossref_primary_10_3390_applmicrobiol4040102
crossref_primary_10_1089_fpd_2023_0118
crossref_primary_10_3390_ani12080976
crossref_primary_10_1089_fpd_2023_0138
Cites_doi 10.1016/S1473-3099(17)30276-1
10.1128/jb.178.14.4157-4165.1996
10.1371/journal.pone.0195259
10.1099/jmm.0.46655-0
10.1371/journal.pone.0112626
10.1093/jac/dki332
10.1128/AAC.00652-07
10.1007/s10482-016-0716-3
10.1128/AAC.00800-08
10.1016/j.fm.2013.12.001
10.1016/j.ijmm.2015.04.005
10.1038/383219a0
10.1128/AAC.01748-17
10.1128/AAC.47.3.1169-1172.2003
10.1093/jac/dkg426
10.1016/j.ijantimicag.2018.02.005
10.1186/1751-0147-52-47
10.3389/fmicb.2016.01896
10.1054/drup.2000.0146
10.1371/journal.pone.0085338
10.1186/s12941-019-0321-1
10.1016/j.jgar.2018.10.014
ContentType Journal Article
Copyright Lippincott Williams & Wilkins
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021
Copyright_xml – notice: Lippincott Williams & Wilkins
– notice: Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
– notice: Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1097/MD.0000000000024970
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1536-5964
EndPage e24970
ExternalDocumentID PMC7969299
33725864
10_1097_MD_0000000000024970
00005792-202103120-00058
Genre Journal Article
GroupedDBID ---
.-D
.XZ
.Z2
01R
0R~
354
40H
4Q1
4Q2
4Q3
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAGIX
AAHPQ
AAIQE
AAMOA
AAQKA
AARTV
AASCR
AAWTL
AAXQO
AAYEP
ABASU
ABBUW
ABCQX
ABDIG
ABFRF
ABOCM
ABVCZ
ABXVJ
ABZAD
ABZZY
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADGGA
ADHPY
ADNKB
ADPDF
AE6
AEFWE
AENEX
AFBFQ
AFDTB
AGOPY
AHOMT
AHQNM
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BQLVK
CS3
DIWNM
DU5
E.X
EBS
EEVPB
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FD6
FIJ
FL-
GNXGY
GQDEL
GROUPED_DOAJ
H0~
HLJTE
HYE
HZ~
H~9
IKREB
IKYAY
IN~
IPNFZ
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
N9A
N~7
N~B
O9-
OAG
OAH
OB2
OHH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OUVQU
OVD
OVDNE
OVEED
OVIDH
OVLEI
OWV
OWW
OWZ
OXXIT
P2P
RIG
RLZ
RPM
RXW
S4R
S4S
TAF
TEORI
TSPGW
UNMZH
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
XYM
YFH
YOC
ZFV
ZY1
AAYXX
CITATION
8L-
ACIJW
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
ODA
7X8
ADSXY
5PM
ID FETCH-LOGICAL-c4508-c0250c1ed599fd6e148ff36d6c373877836dc802f429ecf20464a38d1e23cc303
ISSN 0025-7974
1536-5964
IngestDate Thu Aug 21 18:42:13 EDT 2025
Fri Sep 05 14:31:14 EDT 2025
Wed Feb 19 02:24:43 EST 2025
Tue Jul 01 05:08:46 EDT 2025
Thu Apr 24 23:12:56 EDT 2025
Fri May 16 03:51:08 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4508-c0250c1ed599fd6e148ff36d6c373877836dc802f429ecf20464a38d1e23cc303
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-2095-1781
OpenAccessLink http://dx.doi.org/10.1097/MD.0000000000024970
PMID 33725864
PQID 2502206002
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7969299
proquest_miscellaneous_2502206002
pubmed_primary_33725864
crossref_citationtrail_10_1097_MD_0000000000024970
crossref_primary_10_1097_MD_0000000000024970
wolterskluwer_health_00005792-202103120-00058
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20210312
2021-03-12
2021-Mar-12
PublicationDateYYYYMMDD 2021-03-12
PublicationDate_xml – month: 03
  year: 2021
  text: 20210312
  day: 12
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hagerstown, MD
PublicationTitle Medicine (Baltimore)
PublicationTitleAlternate Medicine (Baltimore)
PublicationYear 2021
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References Lluque (R17-20250504) 2015; 305
Muthuirulandi Sethuvel (R19-20250504) 2019; 16
Hussen (R12-20250504) 2019; 18
Mamishi (R18-20250504) 2019; 31
Rodríguez-Blanco (R27-20250504) 2016; 109
Byrne-Bailey (R25-20250504) 2009; 53
Binet (R11-20250504) 2014; 40
Mohd (R20-20250504) 2014; 9
Yunmin (R16-20250504) 2016; 16
Badhai (R28-20250504) 2016; 7
Waldor (R26-20250504) 1996; 178
Aarestrup (R9-20250504) 2003; 52
Kotloff (R3-20250504) 1999; 77
Liu (R15-20250504) 2018; 13
Bean (R24-20250504) 2005; 56
Vubil (R21-20250504) 2018; 51
Ramachandran (R10-20250504) 2007; 56
Sköld (R5-20250504) 2000; 3
(R1-20250504) 2017; 17
Wu (R22-20250504) 2010; 52
Perreten (R6-20250504) 2003; 47
Darton (R13-20250504) 2018; 62
Bean (R23-20250504) 2009; 53
Waldor (R7-20250504) 1996; 178
Davies (R2-20250504) 1996; 383
Wang (R14-20250504) 2014; 9
References_xml – volume: 17
  start-page: 909
  year: 2017
  ident: R1-20250504
  article-title: Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(17)30276-1
– volume: 178
  start-page: 4157
  year: 1996
  ident: R7-20250504
  article-title: A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139
  publication-title: J Bacteriol
  doi: 10.1128/jb.178.14.4157-4165.1996
– volume: 13
  start-page: e0195259
  year: 2018
  ident: R15-20250504
  article-title: Dominant serotype distribution and antimicrobial resistance profile of Shigella spp. in Xinjiang, China
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0195259
– volume: 56
  start-page: 346
  year: 2007
  ident: R10-20250504
  article-title: Multiplex PCR for detection of antibiotic resistance genes and the SXT element: application in the characterization of Vibrio cholerae[J]
  publication-title: J Med Microbiol
  doi: 10.1099/jmm.0.46655-0
– volume: 9
  start-page: e112626
  year: 2014
  ident: R14-20250504
  article-title: Sulfonamide-resistant bacteria and their resistance genes in soils fertilized with manures from Jiangsu Province, Southeastern China
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0112626
– volume: 56
  start-page: 962
  year: 2005
  ident: R24-20250504
  article-title: Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dki332
– volume: 53
  start-page: 697
  year: 2009
  ident: R25-20250504
  article-title: Prevalence of sulfonamide resistance genes in bacterial isolates from manured agricultural soils and pig slurry in the United Kingdom
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00652-07
– volume: 178
  start-page: 4157
  year: 1996
  ident: R26-20250504
  article-title: A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139
  publication-title: J Bacteriol
  doi: 10.1128/jb.178.14.4157-4165.1996
– volume: 109
  start-page: 1141
  year: 2016
  ident: R27-20250504
  article-title: Unveiling the pan-genome of the SXT/R391 family of ICEs: molecular characterisation of new variable regions of SXT/R391-like ICEs detected in Pseudoalteromonas sp. and Vibrio scophthalmi
  publication-title: Antonie van uwenhoek
  doi: 10.1007/s10482-016-0716-3
– volume: 53
  start-page: 1088
  year: 2009
  ident: R23-20250504
  article-title: Plasmids imparting sulfonamide resistance in Escherichia coli: implications for persistence
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00800-08
– volume: 40
  start-page: 48
  year: 2014
  ident: R11-20250504
  article-title: Rapid detection of Shigella and enteroinvasive Escherichia coli in produce enrichments by a conventional multiplex PCR assay
  publication-title: Food Microbiol
  doi: 10.1016/j.fm.2013.12.001
– volume: 305
  start-page: 480
  year: 2015
  ident: R17-20250504
  article-title: Virulence factors and mechanisms of antimicrobial resistance in Shigella strains from periurban areas of Lima (Peru)
  publication-title: Int J Med Microbiol
  doi: 10.1016/j.ijmm.2015.04.005
– volume: 383
  start-page: 219
  year: 1996
  ident: R2-20250504
  article-title: Bacteria on the rampage
  publication-title: J Nature
  doi: 10.1038/383219a0
– volume: 62
  start-page: e01748-17
  year: 2018
  ident: R13-20250504
  article-title: Azithromycin resistance in Shigella spp. in Southeast Asia
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.01748-17
– volume: 47
  start-page: 1169
  year: 2003
  ident: R6-20250504
  article-title: A new sulfonamide resistance gene (sul3) in Escherichia coli is widespread in the pig population of Switzerland
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.47.3.1169-1172.2003
– volume: 77
  start-page: 651
  year: 1999
  ident: R3-20250504
  article-title: Global burden of Shigella infections: implications for vaccine development and implementation of control strategies
  publication-title: Bull World Health Organ
– volume: 52
  start-page: 715
  year: 2003
  ident: R9-20250504
  article-title: Antimicrobial susceptibility and occurrence of resistance genes among Salmonella enterica serovar Weltevreden from different countries
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkg426
– volume: 51
  start-page: 881
  year: 2018
  ident: R21-20250504
  article-title: Antibiotic resistance and molecular characterization of shigella isolates recovered from children aged less than 5 years in Manhiça, Southern Mozambique
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2018.02.005
– volume: 52
  start-page: 47
  year: 2010
  ident: R22-20250504
  article-title: Prevalence and characterization of plasmids carrying sulfonamide resistance genes among Escherichia coli from pigs, pig carcasses and human
  publication-title: Acta Vet Scand
  doi: 10.1186/1751-0147-52-47
– volume: 7
  start-page: 1896
  year: 2016
  ident: R28-20250504
  article-title: Characterization of three novel SXT/R391 integrating conjugative elements ICEMfulnd1a and ICEMfulnd1b, and ICEMprChn1 identified in the genomes of Marinomonas fungiae JCM 18476T and Marinomonas profundimaris Strain D104
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2016.01896
– volume: 3
  start-page: 155
  year: 2000
  ident: R5-20250504
  article-title: Sulfonamide resistance: mechanisms and trends
  publication-title: Drug Resist Updat
  doi: 10.1054/drup.2000.0146
– volume: 9
  start-page: e85338
  year: 2014
  ident: R20-20250504
  article-title: Plasmid-mediated sulfamethoxazole resistance encoded by the sul2 gene in the multidrug-resistant Shigella flexneri 2a isolated from patients with acute diarrhea in Dhaka, Bangladesh
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0085338
– volume: 31
  start-page: 356
  year: 2019
  ident: R18-20250504
  article-title: Antimicrobial-resistance pattern of Shigella species in children: a six-year study in an Iranian referral Hospital
  publication-title: Ann Ig
– volume: 16
  start-page: 160
  year: 2016
  ident: R16-20250504
  article-title: CHINET Shigella resistance surveillance from 2005 to 2014
  publication-title: Chin J Infect Chemother
– volume: 18
  start-page: 22
  year: 2019
  ident: R12-20250504
  article-title: Prevalence of Shigella species and its drug resistance pattern in Ethiopia: a systematic review and meta-analysis
  publication-title: Ann Clin Microbiol Antimicrob
  doi: 10.1186/s12941-019-0321-1
– volume: 16
  start-page: 215
  year: 2019
  ident: R19-20250504
  article-title: IncFII plasmid carrying antimicrobial resistance genes in Shigella flexneri: vehicle for dissemination
  publication-title: J Glob Antimicrob Resist
  doi: 10.1016/j.jgar.2018.10.014
SSID ssj0013724
Score 2.3883698
Snippet The aim of this study was to discuss the correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri (S. flexneri) and the antibiotic...
The aim of this study was to discuss the correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri ( S. flexneri ) and the...
SourceID pubmedcentral
proquest
pubmed
crossref
wolterskluwer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e24970
SubjectTerms Bacterial Proteins - genetics
Carrier Proteins - genetics
DNA Transposable Elements - genetics
DNA, Bacterial - genetics
DNA, Bacterial - isolation & purification
Dysentery, Bacillary - drug therapy
Dysentery, Bacillary - microbiology
Feces - microbiology
Humans
Microbial Sensitivity Tests
Observational Study
Polymerase Chain Reaction
Shigella flexneri - drug effects
Shigella flexneri - genetics
Shigella flexneri - isolation & purification
Trimethoprim Resistance - genetics
Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology
Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use
Title Correlation between the sulfamethoxazole-trimethoprim resistance of Shigella flexneri and the sul genes
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005792-202103120-00058
https://www.ncbi.nlm.nih.gov/pubmed/33725864
https://www.proquest.com/docview/2502206002
https://pubmed.ncbi.nlm.nih.gov/PMC7969299
Volume 100
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLagk6ZJCHGnXCYj8TYCqdNc_Ahr0YRUENKG9hY5jp1VlKSiiSj79Zxjx2lKxwT0IW2d1HH6fXHO8bkR8jLLmQD9RntS56CgYPJZwWPuBTzxcxXJXBgL_uxjdHI2_nAenm9WlUx0SZ29lpdXxpX8D6rQBrhilOw_INt1Cg3wGfCFLSAM27_C-BhLa1hnts7hCgXJVbPQwtSGXovLaqG8GpP4w9clvB-Bgo1CI97RGLFyMS_QA-pIL9S6hFF3PpXQCxZYbp0MXdWn1haPkuk7sajn1lG3W06YGWH0cyPKpXsommXpxtr2VVlkouqmGlFZ1_2yWM97zY1dlQX6lsVP1027NMGMb1brFK3cdBp5Ibd5yrv51vf7xPJ706cCZdDWEdmZ2W3G4NnEJpy0r52jAZ7lNwN2EMQsTNoTbyfUdrtukj0GuoU_IHufvkynk43xKWZjl6CKx2-uOOcB2Xe9bMszO0rKrq_trR8V-kGsvpowiJ4wc3qH3G61EPrWUuouuaHKe2TfYXufFD1m0ZZZFDhBr2UW3TCLVpo6ZlHHLArMcr1Qw6wH5Oz99PT4xGtLcnhyDKK8J1FkliOVh5zrPFKgTGsdRHkkMUNWjCFBuUx8pkHMUVIzNJyLIMlHigVSgrj0kAzKqlSPCZURqLZKcBVxNo5UJvJEjTI1zgKQwkOth4S5PzaVbb56LJuySJ3fxGyS_g7MkLzqfrS06VquP_yFQyyFaRVtZaJUVbNK4TIZ89FoPSSPLIJdhw76IYm3sO0OwJTt23vK-YVJ3R5zuFrOh8TbYkFqg57N-MKYMw_vJnjcMpP1IUye_HEMT8nB5s57Rgb190Y9BzG5zg7N8tJhS-5fnrO8iQ
linkProvider Ovid
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9NAFB60CyqIeDdeR5A8GW0nySTz0IfSZq3rpgrtuutTmMylu1iSYltd_PWek0vduijYl7RkEkjnJPOdnO98HyGvcs0k5DfWU1ZDgoLis1JEwvNF3NWGKy2rCn464eOj4OAkPGnYFtgLg91nq-Ub3FTPafyCfjiYGM76B1N3khxP-4U7nA77X9xPg3dJ9Z4aWRLuqF9-t2t3MKn4V2EkGMQAQx8DVnVPh_FVssdR36RD9j5-TpLR73pDxIKtuStA7FafSERv01GtcVh_IFtBX-OLa9glYHqZX3nzR4m179XXivp-YQHbv01uNciTDupQuUOumOIuuZY2tfV7ZD5Eo46aGkcb-hYFeEhXm4WVldP0ufxZLoy3RksA-LmELYV0HSEoxA4tLZ2ens2RT0XtwpwXEN1UFro9C53jg_U-OdpPZsOx19gweCoA-OYphEmqZ3QohNXcQAJlrc81V6iKFGEbiFZxl1lY2oyyDIul0o91zzBfKVgiH5BOURbmEaGKQzpjpDAc0j5ucqlj08tNkPuAvEJrHcLaPzZTjUY5WmUssrZWno6yP2fDIa-3By1riY5_D3_ZzlgGtxLWR2Rhys0qg8tkrIuFSoc8rGdwe0IfIiSMeeCQaGdutwNQpnt3T3F2Wsl1RwKuVgiHeDtRkNWNrtnfYvXxf45_Qa6PZ-lhdvh-8uEJuYF7kSvXY09JZ_1tY54BeFrnz5vI_wV6Kg8w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLamTpqQEOK-cDUSyhNBrZM48UMepiZlDNpN6gbjKXJ86SaqpKItDH495-RSKENI9CWt4lpNfWJ_J9_x9xHystBMQn5jPWU1JCgoPitFJDxfxH1tuNKyZvDHE354Fhydh-c7pGNMcfPZcvEaD_U0jW_QDgfzwtPkaOoOp8PkkzvJPk6TiXty8CarH1NjkYR7ko6S726aVF_tyk2Pk06fcZw2IoXNC9KNCFL83RjNl3pk9_hDlqW_eIeIBRuTV4DanU7R37vZXsuuAdTrdZY3v1XIgS8_1yXwvy1ko9vkVotA6UETMnfIjinvkr1xy7HfI7MhGnY0JXK0LeOiABPpcj23snacvpI_qrnxVmgNAB8XcKSQtiMUhRiilaXTi8sZ1lVROzdXJUQ5laXueqEznGDvk7NRdjo89Fo7Bk8FAOM8hXBJDYwOhbCaG0ikrPW55grVkSLcDqJV3GcWljijLEPSVPqxHhjmKwVL5QPSK6vS7BOqOKQ1RgrDIf3jppA6NoPCBIUPCCy01iGs-2Nz1WqVo2XGPO8483Ga_zkaDnm1-dKiker4d_MX3YjlcEshTyJLU62XOVwmY30kLB3ysBnBTYc-REgY88Ah0dbYbhqgXPf2mfLyopbtjgRcrRAO8baiIG82vNa_L4wEg3mLofcGq3f8h_Gj_2z_nOzBnZC_fzt595jcwJNYMjdgT0hv9WVtngKGWhXP2sD_CZE4ELs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Correlation+between+the+sulfamethoxazole-trimethoprim+resistance+of+Shigella+flexneri+and+the+sul+genes&rft.jtitle=Medicine+%28Baltimore%29&rft.au=Ma%2C+Quanping&rft.au=Zhu%2C+Chengbao&rft.au=Yao%2C+Mingxiao&rft.au=Yuan%2C+Guangying&rft.date=2021-03-12&rft.eissn=1536-5964&rft.volume=100&rft.issue=10&rft.spage=e24970&rft_id=info:doi/10.1097%2FMD.0000000000024970&rft_id=info%3Apmid%2F33725864&rft.externalDocID=33725864
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-7974&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-7974&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-7974&client=summon